唐晶;赵丽丽;张硕;姜立刚;

• 1:吉林医药学院附属医院

摘要(Abstract)：

目的探究僵人综合征发病临床表现、免疫学检查、神经电生理(肌电图、黑质超声)特点及治疗方法。方法分析1例僵人综合征患者,并整理其临床资料,同时对临床特点、辅助检查(腹部增强CT、肺部CT、肌电图、黑质超声、血清免疫学检查、血清副肿瘤性神经综合征11项)及治疗经过进行详细梳理。结果本病例临床表现为左下肢肌肉抽搐伴僵硬、疼痛感,肌肉僵直抽搐后伴无力感,共跌倒5～6次,同时伴颈脊旁肌、束脊肌、腹肌肌肉僵直,随之出现肌肉痛性痉挛,免疫学检查超敏C反应蛋白6.4 mg/L(0.1～5.0 mg/L),抗链球菌溶血素"O"36.7 IU/mL(0～200.0 IU/mL),红细胞沉降率40.0 mm/h(0～20.0 mm/h);血清副肿瘤性神经综合征11项:抗GAD65+;多肿瘤标志物11项:甲胎蛋白(AFP)>500ng/mL(0～10.0 ng/mL)。超声提示黑质区回声Ⅱ级。肌电图:针电极提示静息状态下可见正常运动电位单元,被动运动后可见大量运动单位电位,给予地西泮注射后呈静息状态下运动单位电位发放减弱,给予劳拉西泮及巴氯芬治疗后临床症状改善。结论僵人综合征是中枢神经系统自身免疫性疾病引起的一种以下肢肌肉过度收缩和发作性躯干肌、颈脊旁肌、束脊肌及腹部肌肉强直伴疼痛,肌肉僵硬时明显影响患者主动运动为主要特征的临床罕见病。血清GAD65抗体阳性、肌电图显示肌强直,治疗首选药物为苯二氮类药物,还需联用GABA受体激动剂巴氯芬,效果最佳。合并副肿瘤综合征者需加用免疫抑制剂。

关键词(KeyWords)： 僵人综合征;中枢神经系统自身免疫性疾病;抗GAD65;肌电图;黑质超声;苯二氮类;免疫抑制剂

Abstract:

Keywords:

基金项目(Foundation): 吉林省教育厅“十三五”科学技术研究规划项目(编号：JJKH20200459KJ);; 吉林市科技局医疗卫生指导性计划项目(编号：201830481)

作者(Authors): 唐晶;赵丽丽;张硕;姜立刚;

参考文献(References)：

• [1]PATEL K,STUMMER L.Stiff-person syndrome in a patient with comorbid bipolar and panic disorders:A case report and literature review[J].Ment Health Clin,2020,10(3):95-99.DOI:10.9740/mhc.2020.05.095.
• [2]SKORSTAD G,HESTVIK A L,VARTDAL F,et al.Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65in patients with stiff person syndrome[J].J Autoimmun,2009,32(1):24-32.DOI:10.1016/j.jaut.2008.10.002.
• [3]BAIZABAL-CARVALLO J F.The neurological syndromes associated with glutamic acid decarboxylase antibodies[J].J Autoimmun,2019,101:35-47.DOI:10.1016/j.jaut.2019.04.007.
• [4]HINSON S R,LOPEZ-CHIRIBOGA A S,BOWER J H,et al.Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders[J].Neurol Neuroimmunol Neuroinflamm,2018,5(2):e438.DOI:10.1212/NXI.0000000000000438.
• [5]MANHALTER N,GYORFI O,BOROS E,et al.Case report of a woman with anti amphiphysin positive stiff person syndrome[J].Ideggyogy Sz,2017,70(5/6):213-216.DOI:10.18071/isz.70.0213.
• [6]MARTINEZ-HERNANDEZ E,ARINO H,MCKEON A,et al.Clinical and immunologic investigations in patients with stiff-person spectrum disorder[J].JAMA Neurol,2016,73(6):714-720.DOI:10.1001/jamaneurol.2016.0133.
• [7]SOLIMENA M,FOLLI F,DENIS-DONINI S,et al.Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome,epilepsy,and type I diabetes mellitus[J].N Engl J Med,1988,318(16):1012-1020.DOI:10.1056/NEJM198804213181602.
• [8]ALI F,ROWLEY M,JAYAKRISHNAN B,et al.Stiff-person syndrome(SPS)and anti-GAD-related CNS degenerations:protean additions to the autoimmune central neuropathies[J].J Autoimmun 2011,37(2):79-87.DOI:10.1016/j.jaut.2011.05.005.
• [9]BALINT B,VINCENT A,MEINCK H M,et al.Movement disorders with neuronal antibodies:syndromic approach,genetic parallels and pathophysiology[J].Brain,2018,141(1):13-36.DOI:10.1093/brain/awx189.
• [10]ESPLIN N N E,STELZER J W,LEGARE T B,et al.Difficult to Treat a Focal,Stiff Person Syndrome of the Left Upper Extremity[J].Case Rep Neurol Mde,2017,2017:2580620.DOI:10.1155/2017/2580620.
• [11]RAKOCEVIC G,ALEXOPOULOS H,DALAKAS M C.Quantitative clinical and autoimmune assessments in stiff person syndrome:Evidence for a progressive disorder[J].BMC Neurol,2019,19(1):1.DOI:10.1186/s12883-018-1232-z.
• [12]KHAN F,CHEVIDIKUNNAN M F,ALMALKI R A,et al.Stiff-Person Syndrome Outpatient Rehabilitation:Case Report[J].J Neurosci Rural Pract,2020,11(4):651-653.DOI:10.1055/s-0040-1715081.
• [13]BLUM P,JANKOVIC J.Stiff-person syndrome:an autoimmune disease[J].Mov Disord,1991,6:12-20.DOI:10.1002/mds.87006010.
• [14]HORIUCHI K,MARUO Y,MATSUOKA S.Stiff-person syndrome with waldenstrom macroglobulinemia[J].Intern Med,2018,57(22):3313-3316.DOI:10.2169/internalmedicine.1043-18.
• [15]SERVAIS T,LONDON F,DONCKIER J E.Graves’disease as a first autoimmune manifestation of a stiff person syndrome[J].Ann Endocrinol(Paris),2019,80(2):134-136.DOI:10.1016/j.ando.2019.01.002.
• [16]BAIZABAL-CARVALLO J F.The neurological syndromes associated with glutamic acid decarboxylase antibodies[J].J Autoimmun,2019,101:35-47.DOI:10.1016/j.jaut.2019.04.007.
• [17]CAI Q,WU C,XU W,et al.Stiff-person syndrome coexisting with critical illness polyneuropathy:A case report[J].Medicine(Baltimore),2020,99(50):e23607.DOI:10.1097/MD.0000000000023607.
• [18]SCHIRINZI T,SANCESARIO A,ROMANO A,et al.Longitudinal gait assessment in a stiff person syndrome[J].Int J Rehabil Res,2018,41(4):377-379.DOI:10.1097/MRR.0000000000000304.
• [19]DE ALBONIGA-CHINDURZA A,RIVA E,JIMENEZ-HUETEA,et al.Paraneoplastic stiff person syndrome with small cell carcinoma of the bladder and anti-Ri antibodies[J].Clin Neurol Neurosurg,2018,173:194-195.DOI:10.1016/j.clineuro.2018.08.020.
• [20]GALLI J R,AUSTIN S D,GREENLEE J E,et al.Stiff person syndrome with anti-GAD65 antibodies within the national veterans affairs health administration[J].Muscle Nerve,2018,58:801-804.DOI:10.1002/mus.26338.
• [21]ALI F,ROWLEY M,JAYAKRISHNAN B,et al.Stiffperson syndrome(SPS)and anti-GAD-related CNS degenerations:prote-an additions to the autoimmune central neuropathies[J].J Auto-immun 2011,37(2):79-87.DOI:10.1016/j.jaut.2011.05.005.
• [22]HOLMOY T,SKORSTAD G,ROSTE L S,et al.Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord[J].Clin Neurol Neurosurg,2009,111:708-712.DOI:10.1016/j.clineuro.2009.06.005.
• [23]DALAKAS M C,RAKOCEVIC G,DAMBROSIA J M,et al.A double-blind,placebo-controlled study of rituximab in patients with stiff person syndrome[J].Ann Neurol,2017,82 (2):271-277.DOI:10.1002/ana.25002.
• [24]曾桄伦,陈静娟,刘国志,等.僵人综合征1例报道[J].中国实用神经疾病杂志,2018,21(7):805-806.DOI:10.12083/SYSJ.2018.07.202.
• [25]DALAKAS M C.A HSCT TRIAL IN STIFF PERSONSYNDROME:LIMITED BENEFITS HALT ENROLL-MENT BUT SHOULD BE MORE TO COME?[J].Neurology,2020:10.1212/WNL.0000000000011349.DOI:10.1212/WNL.0000000000011349.
• [26]CHEN J,MIN B,ZHANG J Y.A case report of stiff man syndrome[J].J Jilin Med Coll,2019,40(1):33-35.doi:10.13845/j.cnki.issn1673-2995.2019.01.015.
• [27]SCHLERETH T,MA W.The relationship between postherpetic neuralgia pain,central sensitization and anxiety[J].Chin J Pain Med,2015,21(11):806-808.DOI:10.3969/j.issn.1006-9852.2015.11.002.
• [28]SCHR?TER N,WEILLER C,RAUER S,et al.Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor[J].J Neurol,2020 Dec 24.DOI:10.1007/s00415-020-10351-2.
• [29]BAIZABAL-CARVALLO J F,JANKOVIC J.Stiff-person syndrome:insights into a complex autoimmune disorder[J].J Neurol Neurosurg Psychiatry,2015,86(8):840-848.DOI:10.1136/jnnp-2014-309201.
• [30]GODBE K,MALATY G,WENZEL A,et al.McArdle Disease vs.Stiff-Person Syndrome:A Case Report Highlighting the Similarities Between Two Rare and Distinct Disorders[J].Front Neurol,2020,11:529985.DOI:10.3389/fneur.2020.529985.
• [31]LI Y,THAKORE N.An Appraisal of Electrodiagnostic Studies in Stiff Person Syndrome[J].J Clin Neuromuscul Dis,2020,22(2):84-89.DOI:10.1097/CND.0000000000000302.
• [32]YESHOKUMAR A K,SUN L R,NEWSOME S D.Defining the Expanding Clinical Spectrum of Pediatric-Onset Stiff Person Syndrome[J].Pediatr Neurol,2021,114:11-15.DOI:10.1016/j.pediatrneurol.2020.09.007.
• [33]CAFFREY D,FINN C T,SONG S M,et al.Stiff-Person Syndrome and Psychiatric Comorbidities:A Systematic Review[J].Psychosomatics,2020:S0033-3182(20)30239-5.DOI:10.1016/j.psym.2020.08.005.
• [34]VACARAS V,CUCU E E,RADU R,et al.Paraneoplastic Stiff Person Syndrome in Early-Stage Breast Cancer with Positive Anti-Amphiphysin Antibodies[J].Case Rep Neurol,2020,12(3):339-347.DOI:10.1159/000508942.